Catalia Health operates in the healthcare technology sector, focusing on chronic care management and medication adherence. The company serves pharmaceutical manufacturers, health systems, and specialty pharmacies by providing an AI-driven platform called Mabu Care Insights. This platform uses a personal healthcare companion robot named Mabu to engage patients, monitor their treatment adherence, and report data back to caregivers. Catalia Health's business model revolves around selling its platform to healthcare providers and pharmaceutical companies, who benefit from reduced patient readmissions and improved treatment outcomes. The company's revenue is generated through subscription fees and service contracts. Catalia Health leverages relational and behavioral psychology, artificial intelligence, and best medical practices to deliver personalized patient care. Founded on academic research from MIT Media Lab and Boston University Medical Center, the platform has demonstrated effectiveness in clinical studies. The company collaborates with IDEO for human-centered design, ensuring the technology meets real-world patient needs.

Keywords: AI-driven, healthcare companion, chronic care, medication adherence, patient engagement, pharmaceutical, health systems, specialty pharmacies, behavioral psychology, clinical studies.